2022 annual financial data
Korro Bio 2022 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -58,998,000 USD and net income was -58,032,000 USD.
Operating cash flow was -53,645,000 USD.
Get free Korro Bio email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -58,998,000 USD
- Net income
- -58,032,000 USD
- Operating cash flow
- -53,645,000 USD